WIDE RANGE LUMINESCENT IMMUNOASSAYS

• US 20170153231A1
• Filed: 02/10/2017
• Published: 06/01/2017
• Est. Priority Date: 04/16/2012
• Status: Active Grant

• Current Assignee: Access Medical Systems, Ltd.
• Original Assignee: Access Medical Systems, Ltd.
• Inventors: ZUK, Robert F.
• Granted Patent: US 10,451,616 B2
• Time in Patent Office: Days
• CPC Class Codes: G01N 21/66 electrically excited, e.g. electroluminescence
• CPC Class Codes: G01N 21/76 Chemiluminescence; Bioluminescence
• CPC Class Codes: G01N 2458/30 Electrochemically active labels
• CPC Class Codes: G01N 2458/40 Rare earth chelates
• CPC Class Codes: G01N 33/5308 for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
• CPC Class Codes: G01N 33/54306 Solid-phase reaction mechanisms
• CPC Class Codes: G01N 33/582 with fluorescent label

Abstract

The present invention relates to a method for quantitating an analyte having a wide range concentration in a single assay without having to dilute the sample and repeating the assay. The key feature of the invention is having two cycles of events including sample binding to probe, binding reactions, and detection. After the first cycle of binding and detecting, the probe is dipped into the same sample vessel to bind additional analyte in the sample vessel at a condition that is more favorable to binding than the condition in the first cycle.

Claims

1. A method of detecting an analyte in a wide concentration range in a liquid sample, comprising the steps in the order of:

(a) obtaining a probe having a first antibody immobilized on the tip of the probe, wherein the diameter of the tip surface area is ≦

5 mm;

(b) dipping the probe tip into a sample vessel containing a sample solution having an analyte to bind the analyte to the first antibody on the probe tip;

(c) dipping the probe tip into a reagent vessel containing a reagent solution comprising a reagent of a second antibody conjugated with a first member of a binding pair to bind the reagent to the analyte, wherein the first antibody and the second antibody are antibodies against the analyte;

(d) dipping the probe tip into a washing vessel containing a wash solution to wash the probe tip;

(e) dipping the probe tip into an amplification vessel containing an amplification solution comprising a second member of the binding pair conjugated with one or more luminescent labels, to form an immunocomplex of the analyte, the first antibody, the second antibody, and the first and the second members of the binding pair on the probe tip;

(f) obtaining a first result by measuring a luminescent signal of the immunocomplex formed on the probe tip;

(g) dipping the probe tip of (f) without further processing into the same sample vessel and flowing the sample solution laterally in the sample vessel in a more favorable binding condition of a longer reaction time and/or more agitation than step (b), to bind additional analyte in the sample to the first antibody on the probe tip;

(h) repeating steps (c) to (e) 1-10 times to obtain a final immunocomplex; and

(i) obtaining a second result by measuring a luminescent signal of the final immunocomplex formed on the probe tip; and

(j) combining the first and the second results and analyzing the analyte concentration;

whereby the analyte is quantitated over the wide concentration range.

2. The method according to claim 1, wherein said amplification solution comprises a polymer conjugated with at least 5 molecules of the second member of the binding pair and at least 25 molecules of the one or more luminescent labels, wherein the polymer has a molecular weight of at least 1 million Daltons.

3. The method according to claim 1, wherein the diameter of the tip surface area is ≦

about 2 mm.

4. The method according to claim 1, wherein the binding pair is a hapten and its antibody, a ligand and its receptor, complementary strands of nucleic acids, or lectin and carbohydrates.

5. The method according to claim 4, wherein the binding pair is biotin and streptavidin, biotin and avidin, biotin and streptavidin, biotin and neutravidin, fluorescein and anti-fluorescein, digioxigenin and anti-digioxigenin, or DNP and anti-DNP.

6. The method according to claim 5, wherein the first member of the binding pair is biotin and the second member of the binding pair is streptavidin.

7. The method according to claim 1, wherein the polymer is a polysaccharide, a polynucleotide, a dendrimer, a polyols, or polyethylene glycol.

8. The method according to claim 1, wherein the polymer is a branched polysaccharide.

9. The method according to claim 1, wherein the step (h) repeats steps (c) to (e) 1-3 times.

10. The method according to claim 1, wherein the luminescent label is a fluorescent dye selected from the group consisting of:

cyanine, coumarin, xanthene and a derivative thereof.

11. The method according to claim 1, wherein the luminescent label is a chemiluminescent label of ruthenium(II)tris-bipyridine or luminol.

12. The method according to claim 1, wherein the analyte is basic natriuretic peptide, the N-terminal prohormone of brain natriuretic peptide, or procalcitonin.